- Home
- SA vs AZTA Comparison
SA vs AZTA Comparison
Compare SA & AZTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SA
- AZTA
- Stock Information
- Founded
- SA 1979
- AZTA 1978
- Country
- SA Canada
- AZTA United States
- Employees
- SA N/A
- AZTA N/A
- Industry
- SA Precious Metals
- AZTA Industrial Machinery/Components
- Sector
- SA Basic Materials
- AZTA Technology
- Exchange
- SA Nasdaq
- AZTA Nasdaq
- Market Cap
- SA 1.6B
- AZTA 1.4B
- IPO Year
- SA N/A
- AZTA 1995
- Fundamental
- Price
- SA $16.55
- AZTA $30.71
- Analyst Decision
- SA
- AZTA Buy
- Analyst Count
- SA 0
- AZTA 4
- Target Price
- SA N/A
- AZTA $42.00
- AVG Volume (30 Days)
- SA 568.2K
- AZTA 743.9K
- Earning Date
- SA 08-19-2025
- AZTA 08-05-2025
- Dividend Yield
- SA N/A
- AZTA N/A
- EPS Growth
- SA N/A
- AZTA N/A
- EPS
- SA N/A
- AZTA N/A
- Revenue
- SA N/A
- AZTA $668,821,000.00
- Revenue This Year
- SA N/A
- AZTA N/A
- Revenue Next Year
- SA N/A
- AZTA $4.74
- P/E Ratio
- SA N/A
- AZTA N/A
- Revenue Growth
- SA N/A
- AZTA 12.46
- 52 Week Low
- SA $9.40
- AZTA $23.91
- 52 Week High
- SA $20.55
- AZTA $55.64
- Technical
- Relative Strength Index (RSI)
- SA 57.65
- AZTA 49.31
- Support Level
- SA $15.78
- AZTA $27.95
- Resistance Level
- SA $17.05
- AZTA $32.26
- Average True Range (ATR)
- SA 0.51
- AZTA 1.57
- MACD
- SA -0.00
- AZTA -0.17
- Stochastic Oscillator
- SA 70.62
- AZTA 52.32
About SA Seabridge Gold Inc. (Canada)
Seabridge Gold Inc is a development stage company involved in the exploration, and development of gold properties sited in North America. The company's principal projects include the Kerr-Sulphurets-Mitchell property located in British Columbia, the Courageous Lake property located in the Northwest Territories, and Iksut Property located in northwestern British Columbia, and the 3 Aces Project in southeast Yukon. The company has various other mineral resource projects throughout North America.
About AZTA Azenta Inc.
Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has three reportable segments that are Sample Management Solutions, Multiomics, and B Medical Systems. It generates a substantial part of its revenue from its Sample Management Solutions segment.